Trivia of the Civil War

Humor & Entertainment

Davis, W.

Puzzles & Games

Thunder Bay Pr

Changes in the initial stages of the evaluation process over the last decade are reflected in How to Focus an Evaluation. A new book in the series, this volume replaces the first edition′s How to Deal with Goals and Objectives. The volume recognizes that deciding what to evaluate is a complex negotiation process that involves the methodological predisposition of the evaluator and the client, client needs, the nature of the program and the constraints surrounding the evaluation. It outlines five models that characterize different methodological approaches and considers how each may contribute to the focusing process. The text provides advice on how and what type of information to collect from clients, how to clarify and prioritize evaluation concerns, and how to formulate a plan matching evaluation concerns with data collection procedures within cost constraints.

How to Focus an Evaluation (CSE Program Evaluation Kit)

Business & Money

Stecher, Brian

Economics

Sage Publications, Inc.

This festschrift contains 29 scholarly articles in honour of the Museum of Fine Arts, Boston's curator Dows Dunham. Topics range from Egypt, to Nubia, to the Aegean world.

Studies in Ancient Egypt, the Aegean, and the Sudan: Essays in Honor of Dows Dunham

History

Simpson, W.K.

Ancient Civilizations

Museum of Fine Arts, Boston

Over the past 30 years many significant advances have been made in the management of a number of disseminated malignant diseases. The prognosis for diseases such as childhood leukaemia, choriocarcinoma and Hodgkin's disease has gradually been transformed as better anti tumour agents have become available and their clinical use has been refined. During the past 10 years the advent of new agents, particularly cisplatin, bleomycin and the podophyllotoxins, has allowed the cure of disseminated testicular tumours. This degree of success has not, however, been achieved in the case of a number of other common cancers. Ovarian carcinoma is tantalisingly chemo-sensitive and although there are long term survivors from disseminated disease, these are only a small proportion of the total. Breast cancer, although "sensitive" to a multitude of drugs appears to have yielded neither survival benefit, nor cure to the efforts of therapists, while tumours such as those of the colon remain stubbornly unresponsive. Against this backcloth it is apparent that additional more selective treatments are needed if further impact is to be made on the problem of cancer. The development of such agents requires the integration of a multidisciplinary effort encompassing the fields of chemistry, biology and medicine. This symposium provided a forum for clinical and preclinical sCientists, where current aspects of cancer treatment were reviewed and approaches to the development of a new generation of more selective anticancer drugs discussed.

Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983 (Developments in Oncology, 23)

Health, Fitness & Dieting

Harrap, K.R.

Calvert, A.H.

Diseases & Physical Ailments

Springer

See the best price to sell, buy, or rent books by Davis, W.. BookScouter helps to compare book prices from 25+ online bookstores and 30+ buyback vendors with a single search.

Books by Davis, W.